REG - BlackRock Group Medtronic, Inc. - Form 8.3 - Medtronic Inc <Origin Href="QuoteRef">MDT.N</Origin>
RNS Number : 3287TBlackRock Group02 October 2014Ap19
FORM8.3
IRISHTAKEOVERPANEL
DISCLOSUREUNDERRULE8.3OFTHEIRISHTAKEOVERPANEL ACT,1997,TAKEOVERRULES,2013
DEALINGSBYPERSONSWITHINTERESTSINRELEVANTSECURITIESREPRESENTING1%ORMORE
1. KEYINFORMATION
Nameofpersondealing(Note1)
BlackRock, Inc.
Companydealtin
Medtronic, Inc.
Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate(Note2)
$0.10 common shares
Dateofdealing
01 October 2014
2. INTERESTSANDSHORTPOSITIONS
(a) Interestsandshortpositions(followingdealing)intheclassofrelevantsecuritydealtin(Note3)
Long
Short
Number
(%)
Number
(%)
(1)Relevantsecurities
61,511,691 (6.27%)
27,287 (0.00%)
(2)Derivatives(otherthanoptions)
973 (0.00%)
1,292 (0.00%)
(3)Optionsandagreementstopurchase/sell
0 (0.00%)
65,200 (0.00%)
Total
61,512,664 (6.27%)
93,779 (0.00%)
(b) Interestsandshortpositionsinrelevantsecuritiesofthecompany,otherthantheclassdealtin(Note3)
Classofrelevantsecurity:
Long
Short
Number
(%)
Number
(%)
(1)Relevantsecurities
(2)Derivatives(otherthanoptions)
(3)Optionsandagreementstopurchase/sell
Total
Ap20
1. DEALINGS(Note4)
(a) Purchasesandsales
Purchase/sale
Numberofrelevantsecurities
Priceperunit(Note5)
Purchase
603
USD 61.9500
Purchase
37,700
USD 62.4700
Sale
3,476
USD 61.9500
Sale
5,296
USD 62.1437
Sale
5,700
USD 62.1900
Sale
48,900
USD 62.2000
Sale
62,500
USD 62.3009
Sale
1,971
USD 62.4700
Please note: there was also a Transfer In of 66,550 Shares
(b) Derivativestransactions(otherthanoptionstransactions)
Productname,
e.g.CFD
Natureoftransaction
(Note6)
Numberofrelevantsecurities
(Note7)
Priceperunit
(Note5)
TR Swap
Increasing Long
973
USD 0.0000
(c) Optionstransactionsinrespectofexistingrelevantsecurities
(i) Writing,selling,purchasingorvarying
Productname,
e.g.calloption
Writing,selling,purchasing,varyingetc.
Numberofsecurities towhichtheoptionrelates(Note7)
Exercise price
Type,e.g.American,Europeanetc.
Expiry date
Optionmoney paid/receivedperunit(Note5)
(ii) Exercising
Productname,
e.g.calloption
Numberofsecurities
Exercisepriceper unit(Note5)
(d) Otherdealings(includingtransactionsinrespectofnewsecurities)(Note4)
Natureoftransaction
(Note8)
Details
Priceperunit
(if applicable) (Note 5)
Ap21
2. OTHERINFORMATION
Agreements,arrangementsorunderstandingsrelatingtooptionsorderivatives
Fulldetailsofanyagreement,arrangementorunderstandingbetweenthepersondisclosing andanyotherpersonrelatingtothevotingrightsofanyrelevantsecuritiesunderanyoption referredtoonthisformorrelatingtothevotingrightsorfutureacquisitionordisposalofanyrelevant
securitiestowhichanyderivativereferredtoonthisformisreferenced.Ifnone,this shouldbestated.
N/A
IsaSupplementalForm8attached?(Note9) YES
Dateofdisclosure
02 October 2014
Contactname
Tim Dudley
Telephonenumber
+44 20 7743 1540
IfaconnectedEFM,nameofofferee/offerorwithwhichconnected
IfaconnectedEFM,statenatureofconnection(Note10)
Ap23
SUPPLEMENTALFORM8
IRISHTAKEOVERPANEL
DISCLOSUREUNDERRULE8.1ANDRULE8.3OFTHEIRISHTAKEOVERPANELACT,1997,TAKEOVERRULES,2013
DETAILSOFOPENPOSITIONS
(ThisformshouldbeattachedtoForm8.1(a)&(b)(i),Form8.1(b)(ii)orForm8.3,asappropriate)
OPENPOSITIONS(Note1)
Productname,
e.g.calloption
Written,orpurchased
Numberofrelevant securitiestowhichtheoptionorderivativerelates
Exercise price(Note2)
Type,e.g.American,Europeanetc.
Expiry date
Call Option
Written
32,600
USD 64.50
American
03/10/2014
Call Option
Written
32,600
USD 65.00
American
18/10/2014
Notes
1. Wherethereareopenoptionpositionsoropenderivative positions(exceptforCFDs),fulldetailsshouldbegiven.Fulldetailsofanyexistingagreementstopurchaseortosellmust alsobegivenonthisform.
2. Forallpricesandothermonetaryamounts,thecurrencymust bestated.
Forfulldetailsofdisclosurerequirements,seeRule8oftheRules.Ifindoubt,consultthePanel.
This information is provided by RNSThe company news service from the London Stock ExchangeENDISEEALEAEESLFFF
Recent news on Medtronic
See all newsRCS - Cydar Ltd - First patient treated in Medtronic collaboration
AnnouncementRCS - Cydar Ltd - Kenneth Hitchner appointed Cydar Medical Chairman
AnnouncementRCS - Cydar Ltd - Cydar Medical raises $11.5m (£9.3m) in Series A
AnnouncementREG - Baillie GiffordJapan - Net Asset Value(s) <Origin Href="QuoteRef">BGFD.L</Origin> <Origin Href="QuoteRef">MDT.N</Origin>
AnnouncementREG - Goldman Sachs (EPT) Greene King PLC - Form 8.5 (EPT/RI) - Amendment <Origin Href="QuoteRef">GNK.L</Origin> <Origin Href="QuoteRef">MDT.N</Origin>
Announcement